Although mutations in driver genes such as EGFR, KRAS and ALK were reported to be mutually exclusive in majority of NSCLC patients20, we detected 14 cases (4%) carrying mutations in more than one driver genes (Fig. 1B). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.